@article{0eb88985b9c94b3bb66c65c79c031bfa,
title = "A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma",
keywords = "adverse events, best overall response, gemcitabine and pazopanib, soft-tissue sarcoma",
author = "Neeta Somaiah and \{Van Tine\}, \{Brian Andrew\} and Wahlquist, \{Amy E.\} and Milhem, \{Mohammed M.\} and Hill, \{Elizabeth G.\} and Elizabeth Garrett-Mayer and Armeson, \{Kent E.\} and Schuetze, \{Scott M.\} and Meyer, \{Christian F.\} and Reuben, \{Daniel Y.\} and Elias, \{Anthony D.\} and Read, \{William L.\} and Chawla, \{Sant P.\} and Kraft, \{Andrew S.\}",
note = "Publisher Copyright: {\textcopyright} 2020 American Cancer Society",
year = "2021",
month = mar,
day = "15",
doi = "10.1002/cncr.33216",
language = "English",
volume = "127",
pages = "894--904",
journal = "Cancer",
issn = "0008-543X",
number = "6",
}